Anyone can register to listen and see the webinar. Full details will be sent by email on registration. There is no charge to participants.
Speakers in the webinar will discuss the recent Supreme Court decision in Prometheus and the Federal Circuit ruling in Myriad. They will debate the impact of recent developments on gene patents and the medical field and discuss how the USPTO is likely to react.
The webinar is expected to last about an hour and will include short presentations, and an opportunity to ask the panel questions.
The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.
© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.